Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3549809 | 1.00 | TSHR (0.31) | TSHRLMNA | |
| SCHEMBL6133165 | 1.00 | TSHR (0.31) | TSHRLMNA | |
| SCHEMBL28455957 | 0.83 | TSHR (0.31) | TSHR | |
| SCHEMBL12374922 | 0.82 | — | — | |
| SCHEMBL5880313 | 0.81 | TSHR (0.32) | TSHR | |
| SCHEMBL3767455 | 0.81 | TSHR (0.32) | TSHR | |
| SCHEMBL3767458 | 0.81 | TSHR (0.32) | TSHR | |
| SCHEMBL9482960 | 0.80 | MGAM (0.37) | TSHR | |
| SCHEMBL28439843 | 0.80 | MGAM (0.37) | TSHR | |
| SCHEMBL9482958 | 0.80 | MGAM (0.37) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117430526-B | Cefixime side chain ring opening acid impurity and preparation method thereof | 山东金城柯瑞化学有限公司 | 2024-04-02 | — | — | CN | disclosed |
| CN-117510367-B | Preparation method of cefixime side chain open-loop acid | 山东金城柯瑞化学有限公司 | 2024-03-12 | — | — | CN | disclosed |
| CN-117510367-A | Preparation method of cefixime side chain open-loop acid | 山东金城柯瑞化学有限公司 | 2024-02-06 | — | — | CN | disclosed |
| CN-117430526-A | Cefixime side chain ring opening acid impurity and preparation method thereof | 山东金城柯瑞化学有限公司 | 2024-01-23 | — | — | CN | disclosed |
| US-7705142-B2 | Process for the preparation of cefixime | HETERO DRUGS LIMITED (IN) | 2010-04-27 | — | — | US | disclosed |
| EP-1863822-B1 | AN IMPROVED PROCESS FOR THE PREPARATION OF CEFIXIME | HETERO DRUGS LTD (IN) | 2009-10-14 | — | — | EP | disclosed |
| US-20080242858-A1 | Process For the Preparation of Cefixime | HETERO DRUGS LIMITED (IN) | 2008-10-02 | — | — | US | disclosed |
| EP-1863822-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF CEFIXIME | Hetero Drugs Limited (IN) | 2007-12-12 | — | — | EP | disclosed |
| WO-2006103686-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF CEFIXIME | HETERO DRUGS LIMITED (IN) | 2006-10-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080242858-A1 | Process For the Preparation of Cefixime | ACMSD, HAAO, HDHD5 | TSHR 4367/4885LMNA 4102/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.